Blood markers to predict outcome in sepsis patients
Part of Blood & lymphatic, Infections clinical trials.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have sepsis (a severe infection that affects your whole body).
- You cannot be pregnant.
- You cannot have cancer, be on medications that suppress your immune system, or have a blood disorder.
- You cannot have major injuries, burns, severe liver cirrhosis (Child-Pugh Class C), or be on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This trial tests whether a simple blood test (the capillary leak index) can help doctors better predict how sepsis will progress in people recovering from abdominal surgery. If you are in the ICU after surgery for an abdominal infection, this study may help guide your care.
This study is comparing two blood tests (Interleukin 6 and Procalcitonin) to find which is better at detecting sepsis (a serious infection) and predicting the risk of death in burn patients in the ICU. If you have moderate burns and are otherwise healthy, this trial could help improve care for burn victims.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
This study looks at blood markers and a clinical score to help predict the risk of death in people with sepsis in the ICU. It may help doctors identify who needs more aggressive treatment.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
Hear when a new Platelets trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.